Search filters

List of works by Shinya Sato

ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma

Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy

scientific article published on 29 October 2020

Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients

scientific article published on 01 October 2019

Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein

scientific article published on 19 July 2018

Aortic Valve Replacement for the Management of Heyde Syndrome: A Case Report

scientific article

Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites

scientific article published on 10 November 2020

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells

scientific article published on 14 October 2020

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

scientific article published on 13 August 2019

Blocking development of liver fibrosis augments hepatic progenitor cell-derived liver regeneration in a mouse chronic liver injury model

scientific article published on 29 May 2019

Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report

scientific article published on 07 March 2019

Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients

scientific article published on 17 October 2016

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis

scientific article published on 21 March 2020

Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis

scientific article published on 15 July 2019

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

scientific article published on 28 December 2016

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis

scientific article published on 12 December 2018

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B

scientific article published on 27 May 2020

Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis

scientific article published on 20 October 2020

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis

scientific article published on 19 September 2017

Effect of furosemide on muscle cramps in patients with liver cirrhosis

scientific article published on 16 August 2019

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis

scientific article published on 04 August 2020

Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection

Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes

scientific article published on 7 January 2016

Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model

scientific article published on 03 June 2019

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis

scientific article published on 28 April 2020

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2'-deoxycytidine in Hepatic Stellate Cells

scientific article published on 03 June 2020

Identification of clinical risk factors for histological progression of primary biliary cholangitis

scientific article published on 14 June 2019

Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure

scientific article published on 14 May 2020

Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study

scientific article published on 07 September 2019

Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis

scientific article published on 21 July 2016

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.

scientific article

Predictive parameter of tolvaptan effectiveness in cirrhotic ascites

scientific article

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization

scientific article published on 28 June 2017

Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis

scientific article published on 09 October 2018

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

scientific article published on 21 December 2017

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

scientific article published on 4 December 2017

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

scientific article published on 31 December 2020

The effect of three or more administrations of lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center study

scientific article published on 17 June 2020

Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).

scientific article

Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease

scientific article published on 01 October 2019

Treatment of long-segment Barrett's adenocarcinoma by complete circular endoscopic submucosal dissection: a case report.

scientific article published on 19 January 2018

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma

scientific article published on 21 October 2019

[Ruptured ascending colonic varices in a patient with alcoholic liver cirrhosis treated using topical skin adhesive:a case study]

scientific article published on 01 January 2018

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

scientific article published on 25 May 2018

Paulina is supported by:

About Paulina

Help